AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

GUNSYND PLC

Share Issue/Capital Change Jul 2, 2019

7684_rns_2019-07-02_c73e470b-5f64-4c1e-bdee-f83bce897cfb.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1114E

Gunsynd PLC

02 July 2019

Gunsynd plc

("Gunsynd" or the "Company")

Further Investment in Oyster Oil and Gas

Gunsynd (AIM: GUN, ISDX: GUN) announces that it has invested US$130,000 for 108  new ordinary shares in Oyster Oil & Gas Limited ("Oyster"), representing approximately 9.75% of Oyster's enlarged issued share capital.  Gunsynd's total holding following the issue of the new ordinary shares will now represent approximately 30% of the issued share capital of Oyster. 

Funds will be used primarily to meet certain licence obligations relating to the interests held by Oyster in Madagascar.

Oyster has reached an "in principle" agreement with the Government of Madagascar for a two year extension to the current exploration phase, which is subject to certain conditions which include the licence obligations referred to above.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

The directors of Gunsynd accept responsibility for this announcement.

For further information, please contact: 

Gunsynd plc

Hamish Harris
+44 20 7440 0640
Cairn Financial Advisers LLP

James Caithie / Liam Murray / Richard Nash
+44 20 7213 0880
Peterhouse Corporate Finance

Lucy Williams
+44 20 7469 0930

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

FUREAKXFELFNEFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.